|
CN116059378A
(zh)
|
2014-12-10 |
2023-05-05 |
明尼苏达大学董事会 |
用于治疗疾病的遗传修饰的细胞、组织和器官
|
|
CN107921148A
(zh)
|
2015-05-08 |
2018-04-17 |
哈佛学院校长同事会 |
通用供体干细胞和相关方法
|
|
WO2017093969A1
(en)
|
2015-12-04 |
2017-06-08 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
JP2020505025A
(ja)
*
|
2017-01-13 |
2020-02-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
免疫工学的な改変をした多能性細胞
|
|
CA3094322A1
(en)
*
|
2017-03-20 |
2018-09-27 |
Washington University |
Cells and methods of uses and making the same
|
|
WO2018175636A2
(en)
|
2017-03-22 |
2018-09-27 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
IL270835B2
(en)
|
2017-06-12 |
2025-01-01 |
Sinai Health Sys |
Allograft tolerance without the need for systemic immunosuppression
|
|
US11866726B2
(en)
|
2017-07-14 |
2024-01-09 |
Editas Medicine, Inc. |
Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
|
|
WO2020018620A1
(en)
*
|
2018-07-17 |
2020-01-23 |
The Regents Of The University Of California |
Chimeric antigen receptor t cells derived from immunoengineered pluripotent stem cells
|
|
CA3109078A1
(en)
*
|
2018-07-17 |
2020-01-23 |
The Regents Of The University Of California |
Cells differentiated from immunoengineered pluripotent cells
|
|
US12378572B2
(en)
*
|
2018-09-07 |
2025-08-05 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
WO2020067993A1
(en)
*
|
2018-09-26 |
2020-04-02 |
National University Of Singapore |
Engineered human mesenchymal stromal cells with low immunogenicity, methods and kits of generating the same
|
|
UY38427A
(es)
*
|
2018-10-26 |
2020-05-29 |
Novartis Ag |
Métodos y composiciones para terapia con células oculares
|
|
CN111424016A
(zh)
*
|
2019-01-09 |
2020-07-17 |
复旦大学 |
降低细胞免疫原性的诱导型多能干细胞系及建立方法
|
|
KR20210128440A
(ko)
*
|
2019-02-15 |
2021-10-26 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
범용 공여자 줄기 세포 및 관련 방법
|
|
US12221622B2
(en)
*
|
2019-05-10 |
2025-02-11 |
The Regents Of The University Of California |
Modified pluripotent cells
|
|
US11162079B2
(en)
|
2019-05-10 |
2021-11-02 |
The Regents Of The University Of California |
Blood type O Rh-hypo-immunogenic pluripotent cells
|
|
CA3144621A1
(en)
|
2019-06-26 |
2020-12-30 |
The Regents Of The University Of California |
Sirpalpha-silenced natural killer (nk) cells
|
|
TW202115245A
(zh)
*
|
2019-06-27 |
2021-04-16 |
丹麥商諾佛 儂迪克股份有限公司 |
安全免疫隱形細胞
|
|
US20220333082A1
(en)
|
2019-07-10 |
2022-10-20 |
Helmuth Heinrich Kunz |
Methods for deriving autologous and hypoimmunogenic hair follicle containing sheets in vitro
|
|
US20220267732A1
(en)
*
|
2019-08-01 |
2022-08-25 |
Sana Biotechnology, Inc. |
Dux4 expressing cells and uses thereof
|
|
JP7728747B2
(ja)
|
2019-08-23 |
2025-08-25 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃｄ２４発現細胞およびそれらの用途
|
|
PH12022550542A1
(en)
|
2019-09-05 |
2023-03-20 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
CA3150235A1
(en)
*
|
2019-09-05 |
2021-03-11 |
Alireza Rezania |
Universal donor cells
|
|
WO2021050601A1
(en)
*
|
2019-09-09 |
2021-03-18 |
Scribe Therapeutics Inc. |
Compositions and methods for use in immunotherapy
|
|
WO2021055985A1
(en)
*
|
2019-09-22 |
2021-03-25 |
Cellerant Therapeutics, Inc. |
Ipsc-derived, hypoimmunogenic, myeloid progenitor cells
|
|
CN114787351A
(zh)
*
|
2019-10-15 |
2022-07-22 |
加利福尼亚大学董事会 |
通过Fc隔离的移植细胞保护
|
|
WO2021146222A1
(en)
|
2020-01-13 |
2021-07-22 |
Sana Biotechnology, Inc. |
Modification of blood type antigens
|
|
WO2021146471A2
(en)
|
2020-01-15 |
2021-07-22 |
The Regents Of The University Of California |
Transplanted cell protection via inhibition of polymorphonuclear cells
|
|
KR20220142433A
(ko)
|
2020-01-17 |
2022-10-21 |
사나 바이오테크놀로지, 인크. |
유전자 발현 조절용 안전 스위치
|
|
KR20220158046A
(ko)
*
|
2020-03-25 |
2022-11-29 |
사나 바이오테크놀로지, 인크. |
신경계 장애 및 병태의 치료를 위한 면역저하성 신경 세포
|
|
US20230374448A1
(en)
*
|
2020-04-06 |
2023-11-23 |
Rxcell Inc. |
Hypoimmunogenic Cells and Methods and Compositions for Their Production
|
|
EP4138893A4
(en)
*
|
2020-04-21 |
2024-06-12 |
Intima Bioscience, Inc. |
CELLULAR VACCINE PLATFORM AND METHODS OF USE THEREOF
|
|
EP4149525A4
(en)
*
|
2020-05-15 |
2024-08-28 |
Rxcell Inc. |
HYPOIMMUNOGENIC CELLS AND THEIR USES IN IMMUNE RESPONSES
|
|
WO2022036150A1
(en)
|
2020-08-13 |
2022-02-17 |
Sana Biotechnology, Inc. |
Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
|
|
CN112342196A
(zh)
*
|
2020-08-18 |
2021-02-09 |
未来智人再生医学研究院(广州)有限公司 |
一种免疫兼容可逆的通用型多能干细胞及其应用
|
|
WO2022076928A1
(en)
*
|
2020-10-09 |
2022-04-14 |
Sana Biotechnology, Inc. |
METHODS FOR TRIGGERING SAFETY KILLING MECHANISMS USING A CD47-SIRPα BLOCKADE AGENT
|
|
EP4232468A4
(en)
*
|
2020-10-20 |
2025-03-19 |
Replay Holdings, Inc. |
Methods and compositions for cellular therapy
|
|
CN114525255A
(zh)
*
|
2020-10-30 |
2022-05-24 |
未来智人再生医学研究院(广州)有限公司 |
一种表达il-11的多能干细胞衍生物及其应用
|
|
CN114457021A
(zh)
*
|
2020-10-30 |
2022-05-10 |
未来智人再生医学研究院(广州)有限公司 |
一种表达cd47抗体的多能干细胞及其衍生物与应用
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
KR20230118887A
(ko)
|
2020-12-03 |
2023-08-14 |
센츄리 쎄라퓨틱스 인코포레이티드 |
유전자 조작 세포 및 이의 용도
|
|
CN114107211B
(zh)
*
|
2020-12-04 |
2025-09-30 |
未来智人再生医学研究院(广州)有限公司 |
一种多能干细胞及其衍生物
|
|
WO2022125439A2
(en)
*
|
2020-12-07 |
2022-06-16 |
The Regents Of The University Of California |
Innate immune cell silencing by sirp-alpha engager
|
|
WO2022144632A1
(en)
|
2020-12-30 |
2022-07-07 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into nk cells
|
|
JP2024501971A
(ja)
|
2020-12-31 |
2024-01-17 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃａｒ－ｔ活性を調節するための方法及び組成物
|
|
WO2022144855A1
(en)
|
2020-12-31 |
2022-07-07 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
WO2022187379A1
(en)
|
2021-03-03 |
2022-09-09 |
Sana Biotechnology, Inc. |
Immunosuppressive therapies for use with cardiomyocyte cell therapies, and associated methods and compositions
|
|
JPWO2022191216A1
(https=)
*
|
2021-03-09 |
2022-09-15 |
|
|
|
EP4313087A4
(en)
*
|
2021-03-30 |
2025-03-19 |
The Regents of the University of California |
PROTECTION OF TRANSPLANTED CELLS VIA MODIFIED FC RECEPTORS
|
|
KR20240007651A
(ko)
*
|
2021-04-16 |
2024-01-16 |
빔 테라퓨틱스, 인크. |
간세포의 유전적 변형
|
|
AU2022281328A1
(en)
*
|
2021-05-24 |
2023-12-07 |
Sangamo Therapeutics, Inc. |
Ciita targeting zinc finger nucleases
|
|
US20240226164A1
(en)
|
2021-05-27 |
2024-07-11 |
Sana Biotechnology, Inc. |
Hypoimmunogenic cells comprising engineered hla-e or hla-g
|
|
KR20240046319A
(ko)
|
2021-07-14 |
2024-04-08 |
사나 바이오테크놀로지, 인크. |
저면역원성 세포에서의 y 염색체-연결 항원의 변경된 발현
|
|
WO2023008918A1
(ko)
*
|
2021-07-28 |
2023-02-02 |
의료법인 성광의료재단 |
B2m 유전자의 발현이 저해된 유전적으로 조작된 줄기세포 및 이의 이용방법
|
|
EP4384598A1
(en)
|
2021-08-11 |
2024-06-19 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
|
|
AU2022325232A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified primary cells for allogeneic cell therapy
|
|
JP2024535677A
(ja)
|
2021-08-11 |
2024-10-02 |
サナ バイオテクノロジー，インコーポレイテッド |
即時血液媒介性炎症反応を減少させるための同種細胞療法を目的とした遺伝子改変細胞
|
|
US20240358761A1
(en)
|
2021-08-11 |
2024-10-31 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
|
AU2022327174A1
(en)
|
2021-08-11 |
2024-02-15 |
Sana Biotechnology, Inc. |
Inducible systems for altering gene expression in hypoimmunogenic cells
|
|
CN117904109A
(zh)
*
|
2021-08-27 |
2024-04-19 |
浙江大学 |
一种超级增强子核心序列调控b2m基因表达的效果及应用
|
|
US20250313861A1
(en)
|
2021-10-22 |
2025-10-09 |
Sana Biotechnology, Inc. |
Methods of engineering allogeneic t cells with a transgene in a tcr locus and associated compositions and methods
|
|
CN119072319A
(zh)
|
2021-12-23 |
2024-12-03 |
萨那生物技术股份有限公司 |
用于治疗自身免疫性疾病的嵌合抗原受体(car)t细胞及相关方法
|
|
KR20240142624A
(ko)
*
|
2022-01-10 |
2024-09-30 |
사나 바이오테크놀로지, 인크. |
만능줄기세포에서 분화된 면역저하 베타세포 및 관련 용도 및 방법
|
|
US20250302953A1
(en)
|
2022-02-14 |
2025-10-02 |
Sana Biotechnology, Inc. |
Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
|
|
EP4479416A1
(en)
|
2022-02-17 |
2024-12-25 |
Sana Biotechnology, Inc. |
Engineered cd47 proteins and uses thereof
|
|
WO2023173123A1
(en)
|
2022-03-11 |
2023-09-14 |
Sana Biotechnology, Inc. |
Genetically modified cells and compositions and uses thereof
|
|
WO2023183313A1
(en)
|
2022-03-22 |
2023-09-28 |
Sana Biotechnology, Inc. |
Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods
|
|
CN114958768B
(zh)
*
|
2022-06-02 |
2023-03-24 |
健颐生物科技发展(山东)有限公司 |
Fgf10旁分泌通用型人成纤维细胞制剂的制备方法
|
|
CN117343962A
(zh)
*
|
2022-06-29 |
2024-01-05 |
中国科学院上海营养与健康研究所 |
免疫兼容型人多能干细胞、其制备方法及应用
|
|
US20260002124A1
(en)
|
2022-07-01 |
2026-01-01 |
Novo Nordisk A/S |
Enhancing neuronal differentiation of ventral midbrain neural progenitor cells
|
|
WO2024012420A1
(zh)
*
|
2022-07-11 |
2024-01-18 |
士泽生物医药（苏州）有限公司 |
一种表达faslg的通用型细胞及其制备方法
|
|
CN117431217A
(zh)
*
|
2022-07-12 |
2024-01-23 |
上海驯鹿生物技术有限公司 |
表达靶向cd5的嵌合抗原受体(car)的细胞及其应用
|
|
GB202211117D0
(en)
*
|
2022-07-29 |
2022-09-14 |
Replay Holdings Llc |
Compositions and methods for non-immunogenecity
|
|
GB202212144D0
(en)
*
|
2022-08-19 |
2022-10-05 |
Resolution Therapeutics Ltd |
Cells for therapy
|
|
WO2024097313A1
(en)
|
2022-11-02 |
2024-05-10 |
Sana Biotechnology, Inc. |
Methods for producing t cell therapy products
|
|
EP4619015A1
(en)
*
|
2022-11-15 |
2025-09-24 |
The Board of Trustees of the Leland Stanford Junior University |
Hypoallogenic-immunogenic pluripotent stem cells as anti-cancer vaccine
|
|
CN118147077B
(zh)
*
|
2022-12-07 |
2025-09-26 |
士泽生物医药（苏州）有限公司 |
一种表达gsn的通用型细胞及其制备方法
|
|
CN118207165B
(zh)
*
|
2022-12-07 |
2026-03-20 |
士泽生物医药（苏州）有限公司 |
一种表达stc1的通用型细胞及其制备方法
|
|
GB202218755D0
(en)
*
|
2022-12-13 |
2023-01-25 |
Replay Holdings Llc |
Compositions and methods for non-immunogenicity
|
|
WO2024125592A1
(zh)
*
|
2022-12-16 |
2024-06-20 |
士泽生物医药（苏州）有限公司 |
一种通用型细胞及其制备方法
|
|
WO2024151541A1
(en)
|
2023-01-09 |
2024-07-18 |
Sana Biotechnology, Inc. |
Type-1 diabetes autoimmune mouse
|
|
WO2024169917A1
(zh)
*
|
2023-02-16 |
2024-08-22 |
士泽生物医药（苏州）有限公司 |
通用型细胞及其制备方法
|
|
AU2024264889A1
(en)
|
2023-05-03 |
2025-11-13 |
Sana Biotechnology, Inc. |
Methods of dosing and administration of engineered islet cells
|
|
EP4716541A2
(en)
|
2023-05-22 |
2026-04-01 |
Sana Biotechnology, Inc. |
Methods of delivery of islet cells and related methods
|
|
EP4735585A1
(en)
|
2023-06-30 |
2026-05-06 |
Novo Nordisk A/S |
Enhancing neuronal differentiation of neural progenitor cells
|
|
KR102740042B1
(ko)
*
|
2023-07-12 |
2024-12-06 |
㈜바이오솔빅스 |
인간 전분화능 줄기세포로 유래된 심장 오가노이드 제조방법, 효능 및 독성 평가 기술
|
|
WO2025043172A1
(en)
|
2023-08-23 |
2025-02-27 |
Sana Biotechnology, Inc. |
Modified cd47 proteins and their uses
|
|
WO2025054202A1
(en)
|
2023-09-05 |
2025-03-13 |
Sana Biotechnology, Inc. |
Method of screening a sample comprising a transgene with a unique barcode
|
|
CN119351338B
(zh)
*
|
2023-09-15 |
2026-01-23 |
士泽生物医药（苏州）有限公司 |
一种表达cd300ld的低免疫原性细胞及其制备方法
|
|
WO2025096757A1
(en)
|
2023-11-01 |
2025-05-08 |
Sana Biotechnology, Inc. |
Hypoimmunogenic cd22-targeted car t cells for the treatment of relapsed and/or refractory b cell lymphomas
|
|
WO2025151838A1
(en)
|
2024-01-12 |
2025-07-17 |
Sana Biotechnology, Inc. |
Safety switches to control in vitro and in vivo proliferation of cell therapy products
|
|
WO2025230947A1
(en)
|
2024-04-30 |
2025-11-06 |
Satellite Biosciences, Inc. |
Engineered hepatocytes for secreting polypeptides
|
|
WO2025230941A1
(en)
|
2024-04-30 |
2025-11-06 |
Satellite Biosciences, Inc. |
Hypoimmunogenic cell mixtures and methods of use thereof
|
|
CN121006322A
(zh)
*
|
2024-05-22 |
2025-11-25 |
上海苹谱医疗科技有限公司 |
一种通用型工程化细胞及其制备方法与应用
|
|
WO2025259640A1
(en)
*
|
2024-06-14 |
2025-12-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Systems and methods for bioengineering hypoimmunogenic organs, tissues and cells
|